CTSB belongs to a family of lysosomal cysteine proteases, whose expression levels are significantly increased in serum of patients with colorectal cancer compared with matched normal colon subjects [29], suggesting that CTSB may represent a potential target for NP-based drugs in the treatment of colorectal cancer. Here, CTSB is linked to colorectal cancer.